3.2700
-0.0700
(-2.10%)
At close: January 10 at 4:00:01 PM EST
3.2700
0.00
(0.00%)
After hours: January 10 at 4:01:36 PM EST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 2 | 3 | 3 |
Avg. Estimate | -0.29 | -0.37 | -1.81 | -1.58 |
Low Estimate | -0.38 | -0.41 | -1.98 | -1.68 |
High Estimate | -0.13 | -0.33 | -1.5 | -1.42 |
Year Ago EPS | -0.47 | -0.75 | -1.63 | -1.81 |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 2 | 1 | 2 | 2 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
---|---|---|---|---|
EPS Est. | -0.5 | -0.61 | -0.77 | -0.43 |
EPS Actual | -0.47 | -0.75 | -0.48 | -0.37 |
Difference | 0.03 | -0.14 | 0.29 | 0.06 |
Surprise % | 5.37% | -23.81% | 37.35% | 13.02% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.29 | -0.37 | -1.81 | -1.58 |
7 Days Ago | -0.29 | -0.37 | -1.81 | -1.58 |
30 Days Ago | -0.44 | -0.45 | -2.21 | -1.79 |
60 Days Ago | -0.44 | -0.45 | -2.21 | -1.79 |
90 Days Ago | -0.58 | -0.66 | -2.54 | -2.31 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 2 |
Up Last 30 Days | 1 | 1 | 1 | 2 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
AVIR | 38.38% | 50.67% | -10.74% | 12.41% |
S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
Upgrade | Morgan Stanley: Underweight to Equal-Weight | 8/13/2024 |
Downgrade | JP Morgan: Neutral to Underweight | 8/10/2023 |
Maintains | JP Morgan: Neutral | 3/16/2023 |
Maintains | SVB Leerink: Market Perform | 1/27/2023 |
Maintains | Morgan Stanley: Underweight | 1/24/2023 |
Maintains | Morgan Stanley: Underweight | 8/15/2022 |
Related Tickers
IFRX InflaRx N.V.
2.2300
-4.29%
EPIX ESSA Pharma Inc.
1.7400
-4.40%
SEER Seer, Inc.
2.4000
-0.41%
ACHL Achilles Therapeutics plc
1.1850
-0.42%
CNTX Context Therapeutics Inc.
1.0800
-10.74%
XLO Xilio Therapeutics, Inc.
1.1000
-1.79%
CGEM Cullinan Therapeutics, Inc.
11.19
+0.54%
KRON Kronos Bio, Inc.
0.9564
-2.90%
LYEL Lyell Immunopharma, Inc.
0.6040
-7.32%
SNSE Sensei Biotherapeutics, Inc.
0.5125
-3.30%